1346245-20-2

Upstream product

• 1346245-12-2 C₁₆H₁₅N₃O₃ 
• 82031-32-1 7-bromo-1H-quinoxalin-2-one 
• 10272-07-8 3.5-dimethoxyaniline 
• 1346245-13-3 3-chloro-N-(3,5-dimethoxyphenyl)quinoxalin-6-amine 
• 7051-34-5 cyclopropylcarbinyl bromide 

Downstream Products

• 1346243-08-0 N-(cyclopropylmethyl)-N-(3,5-dimethoxyphenyl)-3-(1H-pyrazol-4-yl)quinoxaline-6-amine 
• 1346245-21-3 C₂₈H₃₁N₅O₄ 
• 1346243-30-8 C₂₆H₂₉N₅O₄ 
• 1346243-90-0 C₂₆H₂₇N₅O₂ 
• 1346243-82-0 C₂₅H₂₆BrN₅O₂ 
• 1346243-83-1 C₂₇H₃₁N₅O₃ 
• 1346243-85-3 C₃₁H₃₈N₆O₃ 
• 1346243-86-4 C₂₅H₂₇N₅O₃ 
• 1346246-43-2 C₃₁H₄₁N₅O₃Si 
• 1346243-88-6 C₂₅H₂₈N₆O₄S 
• 1346243-91-1 C₂₆H₃₀N₆O₂ 
• 1346244-07-2 C₂₅H₂₆FN₅O₂ 
• 1431703-24-0 C₂₃H₂₅N₃O₄ 
• 1431703-25-1 C₂₂H₂₅N₃O₃ 

Relevant academic research and scientific papers

ANTICANCER BENZOPYRAZINES VIA THE INHIBITION OF FGFR KINASES

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

PYRAZOLYL QUINAZOLINE KINASE INHIBITORS

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.